3-phenylpyridine has been researched along with 4(5)-phenylimidazole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| DuHadaway, JB; Jaller, D; Kumar, S; LaLonde, JM; Malachowski, WP; Muller, AJ; Patel, B; Prendergast, GC | 1 |
| Ascencao, K; Coukos, G; Dilek, N; Irving, M; Majjigapu, SR; Michielin, O; Pojer, F; Reichenbach, P; Reynaud, A; Röhrig, UF; Vogel, P; Zoete, V | 1 |
2 other study(ies) available for 3-phenylpyridine and 4(5)-phenylimidazole
| Article | Year |
|---|---|
Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase.
Topics: Amino Acid Sequence; Binding Sites; Combinatorial Chemistry Techniques; Computer Simulation; Enzyme Inhibitors; Heme; Humans; Imidazoles; Indoleamine-Pyrrole 2,3,-Dioxygenase; Inhibitory Concentration 50; Iron; Models, Molecular; Quantum Theory; Structure-Activity Relationship | 2008 |
Azole-Based Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
Topics: Azoles; Enzyme Inhibitors; HEK293 Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Molecular Dynamics Simulation; Molecular Structure; Protein Binding; Quantitative Structure-Activity Relationship | 2021 |